According to KYORIN Pharmaceutical's latest financial reports the company has a price-to-book ratio of 0.7655.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.8055 | 5.26% |
2022-12-31 | 0.7652 | -11.13% |
2021-12-31 | 0.8610 | -5.18% |
2020-12-31 | 0.9081 | 1.97% |
2019-12-31 | 0.8906 | -22.66% |
2018-12-31 | 1.15 | 20.46% |
2017-12-31 | 0.9560 | -20.14% |
2016-12-31 | 1.20 | 1.95% |
2015-12-31 | 1.17 | 1.33% |
2014-12-31 | 1.16 | -6.8% |
2013-12-31 | 1.24 | 23.43% |
2012-12-31 | 1.01 | 15.92% |
2011-12-31 | 0.8690 | -11.31% |
2010-12-31 | 0.9798 | -0.71% |
2009-12-31 | 0.9868 | -1.02% |
2008-12-31 | 0.9970 |